Child Trends

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Child Trends sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 3 currently recruiting 7 completed top decile by trial count

Child Trends: 10 sponsored US clinical trials, 3 recruiting.

Child Trends sponsors 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Unprotected Sex, with 4 trials.

Top-decile sponsor footprint

Child Trends ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

3 recruiting of 10 indexed (30% open); 7 completed (70%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Unprotected Sex (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Peers matched on 10 registered trials and 30% open enrollment, not the therapeutic-area sidebar.

Child Trends sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30%40% Total trials Recruiting share Child TrendsAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsCentre hospitalier de l'Université de Montréal (CHUM)Jacques E. ChellyJason SperryMedtronic Cardiac Ablation Solutions
Child Trends sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Child Trends sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 30% open enrollment (± trial volume)

What to do with this Child Trends page

10 registered trials is a research-attention snapshot, not an endorsement of Child Trends or any single study.

  • 3 of Child Trends's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Unprotected Sex is the condition Child Trends studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Unprotected Sex trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Child Trends pipeline card: 10 registered trials from official public datasets.Report a data error.